<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=30803&fmt=gif">

Research Solutions Sets Fiscal Third Quarter 2018 Conference Call for Tuesday, May 15, 2018 at 5:00 p.m. ET

May 1, 2018

ENCINO, Calif., May 1, 2018 /PRNewswire/ -- Research Solutions, Inc. (OTCQB: RSSS), a provider of workflow efficiency solutions for R&D-driven organizations, will hold a conference call on Tuesday, May 15, 2018 at 5:00 p.m. Eastern time to discuss its financial results for the fiscal third quarter ended March 31, 2018. Financial results will be issued in a press release prior to the call.

Research Solutions, Inc. (RSSS) Logo

Research Solutions President and CEO Peter Derycz and CFO Alan Urban will host the conference call, followed by a question and answer period.

Date: Tuesday, May 15, 2018
Time: 5:00 p.m. Eastern time (2:00 p.m. Pacific time)
Toll-free dial-in number: 1-855-327-6837
International dial-in number: 1-631-891-4304
Conference ID: 10004686

Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Liolios Group at 1-949-574-3860.    

The conference call will be broadcast live and available for replay here and via the investor relations section of the company's website at www.researchsolutions.com.   

A replay of the conference call will be available after 8:00 p.m. Eastern time on the same day through May 29, 2018.

Toll-free replay number: 1-844-512-2921
International replay number: 1-412-317-6671
Replay ID: 10004686

About Research Solutions

Research Solutions, Inc. (OTCQB: RSSS) provides workflow efficiency solutions for R&D-driven organizations in life sciences, technology and academia worldwide. Our Software-as-a-Service platform provides tools or "Gadgets" that allow users to discover, access, manage and collaborate around science, technology and medical (STM) content and data. Our customers range from 70+% of the top 25 global pharmaceutical companies to emerging small and medium-sized businesses. We generate recurring revenue from subscriptions to our SaaS platform and transactional revenue from the sale of STM content. For more information, visit www.researchsolutions.com.

 

SOURCE Research Solutions, Inc.

For further information: Investor Relations: Liolios Group, Inc.; Cody Slach; Tel +1 (949) 574-3860; RSSS@liolios.com OR Media Contact: Mitja Alexander Linss; Tel +1 (617) 835-0854; mlinss@reprintsdesk.com


Print Email RSS
print email rss